Stock comparison
ARGENX SE is 32.4x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($56.28 B vs $1.74 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ARGX is larger
ARGENX SE is 32.4x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($56.28 B vs $1.74 B).
Market value leader
ARGX
ARGENX SE is 32.4x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($56.28 B vs $1.74 B).
| Metric | COAG | ARGX |
|---|---|---|
| Market cap | $1.74 B | $56.28 B |
| US-listed rank | #2259 | #296 |
| Net margin | - | - |
| P/E (trailing FY) | - | - |
| SEC filings | 38 | 272 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ARGENX SE is 32.4x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($56.28 B vs $1.74 B).
Full pages: Hemab Therapeutics Holdings, Inc. and ARGENX SE, or browse the full rankings.